Navigation Links
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Date:10/6/2009

ies acquired. The Company has therefore not provided GAAP financial guidance regarding the transaction in this news release. In addition, transaction-related professional fees will be expensed as incurred, under the rules of SFAS 141R.

Excluding the charges discussed above, and on a non-GAAP basis, Gen-Probe's initial expectation is that the acquisition will add approximately $0.05 to the Company's 2010 earnings per share (EPS), based on approximately $15 million in total revenues.

Cooley Godward Kronish is serving as legal counsel to Gen-Probe on this transaction. XMS Capital Partners and Leerink Swann are serving as financial advisers to Prodesse, and Michael Best & Friedrich, LLP is serving as legal counsel.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, go to www.gen-probe.com.

About Non-GAAP Financial Measures

In this news release, non-GAAP EPS excludes non-cash charges such as transaction-related intangible amortization expense, as well as transaction expenses. Gen-Probe's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared and presented in accordance with GAAP. Gen-Probe's management believes that non-GAAP financial measures provide meaningful supplemental information regarding
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
2. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
5. Carl Hull Named President and Chief Operating Officer of Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
7. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
8. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
9. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
10. Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
11. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...nstitute of Standards and Technology (NIST) has de... for detecting and measuring elusive hazards such ...lage in food or pesticides distributed in soil by ...ive than conventional techniques for detecting tra...molecules, having distinct electrically positive a...
(Date:11/18/2009)... Nov. 18 Sangamo BioScie...ata from the University of Pennsylvania investigat...c finger nuclease (ZFN) based product, SB-728-T, f...closed on the internet. ,, Data were presented ...nia School of Medicine from a single subject treat...
(Date:11/18/2009).... 18 Reportlinker.com announces th...s catalogue. ,, Biotechnology Reagents - A Gl...tlinker.com/p0164375/Biotechnology-Reagents---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...emical compounds used in a range of biotech relate...
(Date:11/18/2009)...tly reduces key cardiac enzymes at multiple time p...rican Heart Association 2009 Scientific Sessions ,...rapeutics Inc., a biotechnology company pioneering...apeutics derived from pathogens, today reported re...T-111 (Serp-1), an anti-inflammatory protein deriv...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...AAP Operating Earnings Up 6% - Non-GAAP Di...LTO, Calif., Jan. 23 Varian, Inc.,(NasdaqGS: VARI...37.4,million, representing an increase of 8.9% ove...of fiscal year 2007. The increase was broad-based,...ence and industrial,(which includes environmental,...
... and capabilities to facilitate ...toclave technology provides environmentally ...e addition of the autoclave, one of approximately ...e country capable of treating all types ...pportunity for additional revenue streams - Exp...
...r Molecular,Medicine (CMM) today announced the hir...o support the expansion of the laboratory,s clinic... Jin He, who previously served as a senior lab tec... of Clinical Science, has been hired as,a scientis...medicine from,Anhui Medical University, located in...
Other Biology Technology:Varian, Inc. Reports First Quarter 2008 Results 2Varian, Inc. Reports First Quarter 2008 Results 3Varian, Inc. Reports First Quarter 2008 Results 4Varian, Inc. Reports First Quarter 2008 Results 5Varian, Inc. Reports First Quarter 2008 Results 6Varian, Inc. Reports First Quarter 2008 Results 7Varian, Inc. Reports First Quarter 2008 Results 8Varian, Inc. Reports First Quarter 2008 Results 9Varian, Inc. Reports First Quarter 2008 Results 10Varian, Inc. Reports First Quarter 2008 Results 11Varian, Inc. Reports First Quarter 2008 Results 12Varian, Inc. Reports First Quarter 2008 Results 13Varian, Inc. Reports First Quarter 2008 Results 14Varian, Inc. Reports First Quarter 2008 Results 15Varian, Inc. Reports First Quarter 2008 Results 16Varian, Inc. Reports First Quarter 2008 Results 17Varian, Inc. Reports First Quarter 2008 Results 18Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 2Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 3Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 4The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent 2
(Date:11/22/2009)... A commonly inherited gene deletion can increase t...ne marrow transplantation, an international team o...nline issue of Nature Genetics . When the gene, c...but present in the recipient,s, transplants have a...ct known as graft-versus-host disease, in which im...
(Date:11/22/2009)... Scientists at the Brain Research Centre, a partne...y of Medicine and Vancouver Coastal Health Researc...the mechanism by which brain cells die following a...t damage. The results of the study were recently p...g a stroke, many brain cells continue to die even ...
(Date:11/20/2009)... In a research report published in the November 20...netics.org ), scientists show how a family of gene...ACS genes) are responsible for production of ethyl...pment, and this information lays the foundation fo...ts disease resistant, able to survive and thrive i...
Breaking Biology News(10 mins):Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 1NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 2NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 3The Top 10 Business Mistakes Made By Physician Practices 60292 1The Top 10 Business Mistakes Made By Physician Practices 60292 2Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2 2009 60290 1Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2 2009 60290 2
... has grown new muscle complete with its own networ...d the new muscle in a living mouse. The accomplish...to a report in the June 19 issue of Nature Biotech...f the Technion-Israel Institute of Technology, alo...e of Technology, grew the muscle from scratch by s...
...hat allows the final step in the completion of new...niversity of California, San Diego (UCSD) School o...to a new way to halt tumor growth by cutting off t...Judith Varner, Ph.D., Associate Professor of Medic...oores UCSD Cancer Center, made the surprising disc...
... three molecules –?from a search of 58,000 compoun...lzheimer,s disease. , Each of the three molecules ...opelessly tangled in the brains of patients with A...development of drugs for the disease. , Ken Kosik...te at the University of California, Santa Barbara,...
Other Biology News:New complete muscle grown in the lab 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Scientists discover that three molecules may be developed into new Alzheimer's drugs 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 3
AVR9-8 Stream-Select Valve from Bio-Rad
...eous: Versatile stain for staining RNA (bluish-pur...harides Assay: TLC ≥ 90 % Cation traces:... 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ 5 mg/kg Fe .../kg Mn ≤ 5 mg/kg Na ≤ 50 mg/kg Ni X...
... Tpersonal thermocycler provides maximum performan... Peltier elements, high heating and cooling rates ...s. With a maximum capacity of 48 x 0.2ml tubes, th...e expensive 96 well instruments. Alternatively, th...
...Deparaffinization Solution is available in a ready...gent for dewaxing paraffin-embedded tissue section...u hybridization, or other analytical methods. The ...f dipping the slides in a series of baths of xylen...
Biology Products: